Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 126 for “"Active pharmaceutical ingredient (API )"”.

  1. Rapid active pharmaceutical ingredient (API) identification of unknown tablets using portable Raman spectroscopy for on-scene analysis

    … of utilizing a handheld Raman spectrometer for rapid on-site detection of pharmaceutical tablets in a two-part experiment. The Rigaku. CQL Max-ID handheld 1064 nm Raman Analyzer was used to detect the active pharmaceutical ingredient (API) of forty randomly selected tablets. Three scans were …

    bu Repository record for Rapid active pharmaceutical ingredient (API) identification of unknown tablets using portable Raman spectroscopy for on-scene analysis (opens in a new tab)

  2. The Effect of a Source Change for an Active Pharmaceutical Ingredient (API) or Excipient on the Finished Drug Product

    … product, with the main cost factor being the active pharmaceutical ingredient and some of the excipients used in the manufacture of the drug product. These companies are expected to follow the required guidelines set out by the international regulatory authorities and more specifically of the …

    waterloo Repository record for The Effect of a Source Change for an Active Pharmaceutical Ingredient (API) or Excipient on the Finished Drug Product (opens in a new tab)

  3. Investigations into the Synthesis, Identification and Developability of Active Ionic Liquids

    … have largely been used as solvents in the pharmaceutical industry. An active ionic liquid (AIL) contains an active pharmaceutical ingredient (API) as one of the counterions. They have to potential to be advantageous in traditional oral and alternative non-oral routes of administration. The …

    ku Repository record for Investigations into the Synthesis, Identification and Developability of Active Ionic Liquids (opens in a new tab)

  4. Methods for Increasing Sensitivity and Throughput of Solid-State NMR Spectroscopy of Pharmaceutical Solids

    … structure, and dynamics of a pure or formulated active pharmaceutical ingredient (API). To overcome the major shortcomings of SSNMR, acquisition time and sensitivity, a two-sample probe was designed, developed, and tested. The probe allowed for two samples to be acquired simultaneously while …

    ku Repository record for Methods for Increasing Sensitivity and Throughput of Solid-State NMR Spectroscopy of Pharmaceutical Solids (opens in a new tab)

  5. Effects of API particle size on the dissolution rate in molten polymer excipient matrices during hot melt extrusion, conducted in a co-rotating twin-screw extruder

    The effect of the Active Pharmaceutical Ingredient (API) particle size on the dissolution rate in the polymer excipient during hot melt extrusion is investigated using a co-rotating twin-screw extruder with three different screw configurations. Acetaminophen (APAP) and amphiphilic polyvinyl …

    njit Repository record for Effects of API particle size on the dissolution rate in molten polymer excipient matrices during hot melt extrusion, conducted in a co-rotating twin-screw extruder (opens in a new tab)

  6. Preparation of nanovehicles for targeted drug delivery

    Application of nanotechnology in pharmaceutical research has opened new frontiers for drug development and its efficient delivery. In recent years, the focus of the research has been on the engineering of nano/micro-particulate structures for efficient and targeted delivery of drugs for selective …

    njit Repository record for Preparation of nanovehicles for targeted drug delivery (opens in a new tab)

  7. Polymer Coated Microneedles, A Novel Technology for Drug Delivery and Sampling

    … it is safe and effective to release the active pharmaceutical ingredient (API) under controlled release, excluding the excipients. In the first chapter, Polymer-Coated Polymeric (PCP) microneedles were fabricated using PVP K 30 for the core and ethyl cellulose for the coating. When PCP …

    mississippi Repository record for Polymer Coated Microneedles, A Novel Technology for Drug Delivery and Sampling (opens in a new tab)

  8. Development of Gastroretentive Floating Pellets Using Hot Melt Extrusion

    … All components of the formulations including the active pharmaceutical ingredient (API) of the drug (theophylline), the polymers acting as a floating matrix and achieving the adhesive function (chitosan, HPC HF, HPMC K4M, and PEO N80), and the gas generating agent sodium bicarbonate were directly …

    mississippi Repository record for Development of Gastroretentive Floating Pellets Using Hot Melt Extrusion (opens in a new tab)

  9. Co-crystal screening of poorly water-soluble active pharmaceutical ingredients. Application of hot stage microscopy on curcumin-nicotinamide system and construction of ternary phase diagram of fenbufen-nicotinamide-water co-crystal system.

    … compound suffers from poor bioavailability and rapid neutral-alkaline degradation. Co-crystal of curcumin is one option under exploration, motivated by the fact that a number of active pharmaceutical ingredient (API) co-crystals with improved dissolution have recently been synthesized. Hence, …

    bradford Repository record for Co-crystal screening of poorly water-soluble active pharmaceutical ingredients. Application of hot stage microscopy on curcumin-nicotinamide system and construction of ternary phase diagram of fenbufen-nicotinamide-water co-crystal system. (opens in a new tab)

  10. Non-conventional polymers as matrix excipients for hot melt extruded oral-release formulations

    … Moreover, formulations containing 3 components (active pharmaceutical ingredient (API), polymer and other additional excipient) have been extensively described in literature. If the characteristics of an extrudate containing API and polymer does not meet the requirements, a third component …

    ghent Repository record for Non-conventional polymers as matrix excipients for hot melt extruded oral-release formulations (opens in a new tab)

  11. New route to the API Ropinirole Hydrochloride and towards new synthetic applications of squaramides

    … our efforts in developing a new synthesis of the active pharmaceutical ingredient (API) ropinirole hydrochloride, used in the symptomatic treatment of Parkinson’s disease and Restless Leg Syndrome. The API in Requip™ (marketed by GlaxoSmithKline) is currently prepared in 12% overall yield using a …

    soton Download PDF for New route to the API Ropinirole Hydrochloride and towards new synthetic applications of squaramides (opens in a new tab)

  12. An investigation of the potential for and application of life cycle analysis in the pharmaceutical industry

    … have been made to apply this method to the pharmaceutical industry. The Toxic Release Inventory is a powerful tool to determine areas of high potential for emissions reductions in industry. When applied to the pharmaceutical industry and coupled with a life cycle assessment, areas for …

    rowan Repository record for An investigation of the potential for and application of life cycle analysis in the pharmaceutical industry (opens in a new tab)

  13. Varied Bulk Powder Properties of Micro Sized API within Size Specifications as A Result of Particle Engineering Methods

    Micronized particles of an active pharmaceutical ingredient (API) are commonly used to improve the content uniformity (CU), dissolution performance, and bioavailability of pharmaceutical products. Many techniques have been developed to prepare micronized API using different routes of particle …

    umn Repository record for Varied Bulk Powder Properties of Micro Sized API within Size Specifications as A Result of Particle Engineering Methods (opens in a new tab)

  14. DEM-CFD analysis of micromechanics for dry powder inhalers

    … are examined. For the mixing of carrier and active pharmaceutical ingredient (API) particles in a vibrating container, it is found that vibration conditions affect the mixing performance. While there is an optimal mixing condition to maximise the number of API particles attaching to the …

    birmingham Download PDF for DEM-CFD analysis of micromechanics for dry powder inhalers (opens in a new tab)

  15. Study of controlled release of dapsone from modified montmorillonite and polymer matrices

    … release system of Dapsone (DAP) as the Active Pharmaceutical Ingredient (API) intercalated into sodium montmorillonite (MMT-Na+) and their combination with an anionic copolymer (Eudragit S100). The effects of the excipients on the API dissolution rate were studied from their release …

    njit Repository record for Study of controlled release of dapsone from modified montmorillonite and polymer matrices (opens in a new tab)

  16. Cocrystals of Nutraceuticals: Protocatechuic Acid and Quercetin

    … is of a great academic and industrial interest. Pharmaceutical cocrystallization has allured a lot of attention by means of altering the physicochemical properties of Active Pharmaceutical Ingredient (API) such as solubility, stability and bioavailability. Crystal engineering of nutraceuticals …

    usf Repository record for Cocrystals of Nutraceuticals: Protocatechuic Acid and Quercetin (opens in a new tab)

  17. Flow properties of selected pharmaceutical powders

    In the pharmaceutical industry uniform flow of powders is one of the most important considerations in solid dosage manufacture. Improper feeding of powders from storage hoppers into dye-presses can lead to inconsistent product quality, causing economic and health impacts. Investigation into the …

    sask Repository record for Flow properties of selected pharmaceutical powders (opens in a new tab)

  18. Synthesis and structure determination of new pharmaceutical cocrystals

    Pharmaceutical cocrystals have an important and influential role in the pharmaceutical industry through the formation of substitutional crystalline material to obtain the optimum physical properties of an active pharmaceutical ingredient (API) without changing its chemical properties. Pyrazinamide …

    birmingham Download PDF for Synthesis and structure determination of new pharmaceutical cocrystals (opens in a new tab)

  19. Development of a Chromatographic Method to Authenticate Aspirin Brands

    Counterfeit pharmaceuticals pose a threat to society that can include inaccurate amounts of the active pharmaceutical ingredient (API), no API, or containing off-target compounds. For example, there are many recent examples of counterfeit pharmaceuticals containing potentially lethal doses (> 2 mg) …

    sdstate Repository record for Development of a Chromatographic Method to Authenticate Aspirin Brands (opens in a new tab)

  20. Cyclic Dipeptides and Alpha Lipoic Acid Forms for the Design of Pharmaceutical and Nutraceutical Co-crystals

    … materials combining the molecules of an active pharmaceutical ingredient (API) and an excipient in the same crystal structure. Five cyclic dipeptides and four α-lipoic acid forms were utilized in this work as potential co-crystal co-formers. Over 120 binary combinations were tested using …

    guelph Repository record for Cyclic Dipeptides and Alpha Lipoic Acid Forms for the Design of Pharmaceutical and Nutraceutical Co-crystals (opens in a new tab)

Page 1 of 7